Inovio Pharmaceuticals Investor Relations Material
Latest events
Q1 2025
Inovio Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Inovio Pharmaceuticals Inc
Access all reports
Inovio Pharmaceuticals Inc is a biotechnology company focused on the discovery, development, and commercialization of DNA medicines. The company’s research areas include infectious diseases, cancer immunotherapy, and rare diseases. Inovio develops DNA-based immunotherapies and vaccines delivered through its proprietary platform. The company is headquartered in Plymouth Meeting, Pennsylvania, and its shares are listed on the NASDAQ.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
INO
Country
🇺🇸 United States